Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women.

Author: ChoiI S, HwangH Y, JinD K, KangM H, KimD S, KimW, KohK K, LeeS K, ShinE K, YangS H

Paper Details 
Original Abstract of the Article :
BACKGROUND: Synthetic, not natural, progestagen may negate the favorable effects of estrogen. Nonetheless, observational studies report no differences in risk for clinical cardiovascular events between users of unopposed estrogen and users of estrogen combined with synthetic progestin. METHODS AND ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1161/01.cir.103.15.1961

データ提供:米国国立医学図書館(NLM)

Estrogen Plus Progestagen: Navigating the Vascular Landscape of Menopause

This double-blind study investigates the [vascular effects] of [synthetic and natural progestagens] combined with [conjugated equine estrogen (CEE)] in [healthy postmenopausal women]. The authors compared the effects of micronized progesterone (MP) and medroxyprogesterone acetate (MPA) on flow-mediated dilation, markers of inflammation, hemostasis, and fibrinolysis. They found that both CEE+MP and CEE+MPA significantly improved endothelium-dependent vasodilator responsiveness and had similar effects on markers of inflammation, hemostasis, and fibrinolysis inhibition. The study provides valuable insights into the vascular effects of different progestagens in combination with estrogen during menopause.

The Crossroads of Estrogen and Progestagen: A Vascular Perspective

The study sheds light on the complex interplay between estrogen and progestagen on vascular health during menopause. The findings suggest that both synthetic and natural progestagens, when combined with estrogen, can have beneficial effects on vascular function. This information is important for women considering hormone therapy during menopause, as it can help guide the selection of appropriate hormone regimens. It's like having a guide to navigate the diverse landscape of menopausal hormone therapy, ensuring you choose the right path for your vascular health.

Menopause: A Dr.Camel Perspective

As a physician, I understand the importance of providing women with personalized guidance regarding hormone therapy during menopause. This research provides valuable insights into the vascular effects of different progestagens, helping women make informed decisions about hormone regimens based on their individual needs and preferences. It's like choosing the right camel for a long journey - selecting the right hormone therapy can make a significant difference in a woman's overall health and well-being during menopause.

Dr.Camel's Conclusion

This study suggests that both CEE+MP and CEE+MPA provide similar improvements in vascular function and markers of inflammation, hemostasis, and fibrinolysis inhibition in healthy postmenopausal women. The findings highlight the importance of considering individual factors when choosing a hormone therapy regimen for menopause.

Date :
  1. Date Completed 2001-05-10
  2. Date Revised 2019-06-23
Further Info :

Pubmed ID

11306524

DOI: Digital Object Identifier

10.1161/01.cir.103.15.1961

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.